Evaluating the clinical significances of serum HE4 with CA125 in peritoneal tuberculosis and epithelial ovarian cancer

References

• Angioli R, Plotti F, Capriglione S, et al. (2013). Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol 128:579–83.
   PubMed Web of Science ®Google Scholar
• Azzam AZ, Hashad DI, Kamel NA. (2013). Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward? Arch Gynecol Obstet 288:167–72.
   PubMed Web of Science ®Google Scholar
• Choi CH, Kim CJ, Lee YY, et al. (2010). Peritoneal tuberculosis: a retrospective review of 20 cases and comparison with primary peritoneal carcinoma. Int J Gynecol Cancer 20:798–803
   PubMed Web of Science ®Google Scholar
• Chudecka-Glaz AM, Cymbaluk-Ploska AA, Menkiszak JL, et al. (2014). Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. J Ovarian Res 7:62
   PubMed Web of Science ®Google Scholar
• Elmore RG, Li AJ. (2007). Peritoneal tuberculosis mimicking advanced-stage epithelial ovarian cancer. Obstet Gynecol 110:1417–19
   PubMed Web of Science ®Google Scholar
• Ferraro S, Braga F, Lanzoni M, et al. (2013). Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol 66:273–81
   PubMed Web of Science ®Google Scholar
• Georgakopoulos P, Mehmood S, Akalin A, Shroyer KR. (2012). Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary. Int J Gynecol Pathol 31:517–23
   PubMed Web of Science ®Google Scholar
• Gosein MA, Narinesingh D, Narayansingh GV, et al. (2013). Peritoneal tuberculosis mimicking advanced ovarian carcinoma: an important differential diagnosis to consider. BMC Res Notes 6:88
   PubMedGoogle Scholar
• Hamed EO, Ahmed H, Sedeek OB, et al. (2013). Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response. Diagn Pathol 8:11
   PubMed Web of Science ®Google Scholar
• Hede K. (2009). Small RNAs are raising big expectations. J Natl Cancer Inst 101:840–1
   PubMedGoogle Scholar
• Huang WC, Tseng CW, Chang KM, et al. (2011). Usefulness of tumor marker CA-125 serum levels for the follow-up of therapeutic responses in tuberculosis patients with and without serositis. Jpn J Infect Dis 64:367–72
   PubMed Web of Science ®Google Scholar
• Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. (2014). Ovarian cancer. Lancet 384:1376–88
   PubMed Web of Science ®Google Scholar
• Jung EY, Hur YJ, Lee YJ, et al. (2015). Peritoneal carcinomatosis mimicking a peritoneal tuberculosis. Obstet Gynecol Sci 58:69–72
   PubMedGoogle Scholar
• Lalvani A. (2007). Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131:1898–906
   PubMed Web of Science ®Google Scholar
• Lataifeh I, Matalka I, Hayajneh W, et al. (2014). Disseminated peritoneal tuberculosis mimicking advanced ovarian cancer. J Obstet Gynaecol 34:268–71
   PubMedGoogle Scholar
• Lin J, Qin J, Sangvatanakul V. (2013). Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 167:81–5
   PubMed Web of Science ®Google Scholar
• Lin JY, Qin JB, Li XY, et al. (2012). Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 13:5427–32
   PubMedGoogle Scholar
• Liu Q, Zhang Q, Guan Q, et al. (2014). Abdominopelvic tuberculosis mimicking advanced ovarian cancer and pelvic inflammatory disease: a series of 28 female cases. Arch Gynecol Obstet 289:623–9
   PubMed Web of Science ®Google Scholar
• Liu W, Yang J, Chi PD, et al. (2013). Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis. Int J Tuberc Lung Dis 17:1346–53
   PubMed Web of Science ®Google Scholar
• Muroni M, Rouet A, Brocheriou I, Houry S. (2015). Abdominal tuberculosis: utility of laparoscopy in the correct diagnosis. J Gastrointest Surg 19:981–3
   PubMed Web of Science ®Google Scholar
• Ortiz-Muñoz B, Aznar-Oroval E, García GA, et al. (2014). HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer. Tumour Biol 35:7249–58
   PubMed Web of Science ®Google Scholar
• Raviglione M, Marais B, Floyd K, et al. (2012). Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379:1902–13
   PubMed Web of Science ®Google Scholar
• Stiekema A, Boldingh QJ, Korse CM, et al. (2015). Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin. Gynecol Oncol 136:562–6
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang JJ, Huang HF, et al. (2012). Comparison between peritoneal tuberculosis and primary peritoneal carcinoma: a 16-year, single-center experience. Chin Med J (Engl) 125:3256–60
   PubMed Web of Science ®Google Scholar
• Xi X, Shuang L, Dan W, et al. (2010). Diagnostic dilemma of abdominopelvic tuberculosis: a series of 20 cases. J Cancer Res Clin Oncol 136:1839–44
   PubMed Web of Science ®Google Scholar
• Zhen S, Bian LH, Chang LL, Gao X. (2014). Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: a meta-analysis. Mol Clin Oncol 2:559–66
   PubMedGoogle Scholar
• Zhuang H, Gao J, Hu Z, et al. (2013). Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma. PLoS One 8:e68994
   PubMed Web of Science ®Google Scholar